One of the common questions that Im getting these days is: Would we see the same result with other GLP-1s or with other biologics
GLP-1 receptor activation suppresses appetite by slowing gastric emptying, increasing central satiety signalling in the hypothalamus, and triggering glucose-dependent insulin secretion from pancreatic beta cells [1]
The cortisol elevation is mediated through stimulation of hypothalamic corticotropin-releasing hormone (CRH) release, which in turn activates the pituitary-adrenal axis
Nicotinamide Mononucleotide(NMN) supplementation restores redox balance in the liver through the SIRT3-NRF2 axis, protecting the aged liver from oxidative stress-induced damage [76]
External resources STEP 1 Trial: Semaglutide in Adults with Overweight or Obesity (NEJM) SURMOUNT-1 Trial: Tirzepatide for Treatment of Obesity (NEJM) NIH BMI Calculator (National Heart, Lung, and Blood Institute) For researchers serious about navigating GLP-1 eligibility and optimizing their treatment protocols, SeekPeptides offers the most comprehensive resource available
Clinical trials show that when combined with lifestyle changes, users may lose 10-15% of their body weight
